ArticleThe Journal of veterinary medical science2025
Clinical efficacy of anti-programmed death ligand 1 antibody HFC-L1/c4G12 in dogs with malignant tumors: an exploratory study.
Satoshi Takagi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.